EF
MIRM icon

Empowered Funds’s Mirum Pharmaceuticals MIRM Stock Holding History

Empowered Funds’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,386
Closed -$1.73M – 1811
2025
Q1 		$1.73M Buy
38,386
+5,120
+15% +$241K 0.02% 814
2024
Q4 		$1.38M Buy
+33,266
New +$1.39M 0.02% 884

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Empowered Funds's MIRM Position: Q2 2025 in Review

Empowered Funds sold out of Mirum Pharmaceuticals (MIRM) in Q2 2025, closing a stake of 38,386 shares — an estimated $1.73M sold.

Empowered Funds first reported a position in MIRM in Q4 2024 and held it in 2 quarters. The position peaked at $1.73M in Q1 2025. 214 funds tracked by Wall St. Rank hold MIRM as of Q2 2025.

  • Empowered Funds reported no remaining Mirum Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Empowered Funds sold 38,386 Mirum Pharmaceuticals shares in Q2 2025, an estimated $1.73M.
  • Empowered Funds first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • Empowered Funds's Mirum Pharmaceuticals position peaked at $1.73M in Q1 2025.
  • 214 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2025.

Based on Empowered Funds's 13F filing for Q2 2025, filed 11 Aug 2025.